| Pravachol |
All Financial Data in US $ (mln) |
| Word Search (Top 10 - by date) |
Celera Publishes Review Article on the KIF6 Gene Variant as a Predictor of Risk of Coronary Heart Disease (CHD) and Reduction in Coronary Events from Statin Therapy
Celera
(August 18, 2010)
|
Celera Announces CE Mark for KIF6 Test
Celera
(June 07, 2010)
|
Celera Presents Data Describing the Biology of KIF6, a Genetic Marker for the Management of CHD
Celera
(April 12, 2010)
|
Sigma Announces A$389 Million Loss Due to Impairment of Goodwill
Sigma Pharmaceuticals
(March 31, 2010)
|
Celera Publishes Data Extending the Association Between the KIF6 Gene Variant and Differential Reduction of Coronary Events from Statin Therapy to the Elderly with Prior Vascular Disease
Celera
(March 24, 2010)
|
Cobalis Partners with The Sandino Group to Manage its Direct To Consumer (DTC) Television Advertising Campaign for Anti-Allergy Product "PreHistin®, The World's FIRST Pre-Histamine"
Cobalis
(February 10, 2010)
|
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Eli Lilly
(December 23, 2009)
|
Tibotec Therapeutics Launches Grace Campaign for Women and People of Color Living With HIV/AIDS
Johnson & Johnson
(December 01, 2009)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.
|
| Summary Product Name Information |
|
|
| Product Sales Summary 2007/08 |
|
Annual Sales WW - Sales
|
Growth per Year (%)
|
|
Rank1 |
Generic Name
|
Therapeutic Subcategory
|
2007 |
2008
|
2008 |
| Pravachol2 |
|
|
|
443 |
203 |
|
-54% |
|
|
Note: Shaded Cells3 |
|
|
More Product Information for EvaluatePharma® subscribersSubscribers see:
- Sales (historic and forecast to 2016 where available) listed by the reporting company or companies, including royalty, license and JV revenue where applicable
- Details of all events impacting the product
- Detailed product information, including sales forecasts listed by the reporting company or companies, indications (approved and in trial)
|
Register to access more FREE content:
- 2009 Product Sales analysis
- Download analysis into Excel
- Search 2 yrs of company press releases
|
|
|
|